Semglee Injection, Solution
Product Images NDC 83257-012

34 FDA label images from Biocon Biologics Inc. · Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 34 technical images submitted to the FDA as part of the official labeling for Semglee (NDC 83257-012). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Biocon Biologics Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Instructions For Use Figure K (Image 23)

Instructions For Use Figure K (Image 23)
An instructional illustration showing a hand holding a SEMGLEE injection pen. The image highlights the step of attaching a needle to the pen, indicated by an arrow pointing upward, with a close-up inset of a needle being connected to the pen cap.*
FDA Label Image

Instructions For Use Figure L (Image 24)

Instructions For Use Figure L (Image 24)
The image shows a Semglee insulin glargine-yfgn injection syringe, solution for subcutaneous use. The syringe is labeled with Semglee branding and strength of 100 units per mL. It features a transparent barrel with measurement markings and a blue label indicating the product and its manufacturer, Biocon Biologics Inc.*
FDA Label Image

Instructions For Use Figure M (Image 25)

Instructions For Use Figure M (Image 25)
An instructional illustration showing two hands holding a Semglee (insulin glargine-yfgn) injection pen. The pen is labeled for subcutaneous use and indicates a 100 units/mL concentration, highlighting details relevant for dosage and administration.*
FDA Label Image

Figure-f (Figure F)

Figure-f (Figure F)
An instructional illustration showing a close-up of two fingers holding the cap of a pen-shaped injection device, with an arrow indicating the action of twisting or pulling the cap off. This likely demonstrates the step of removing the cap before using the injection device.*
FDA Label Image

Figure-h (Figure H)

Figure-h (Figure H)
Instructional illustration demonstrating the removal of the inner cap from an injection vial or pen, with text indicating to 'Keep outer cap.' The image shows a hand lifting the inner cap vertically while retaining the outer cap attached to the vial or pen.*
FDA Label Image

Figure-i (Figure I)

Figure-i (Figure I)
Instructional illustration showing a hand removing the inner cap from a syringe or pen needle with a directive to throw the inner cap away into a sharps container. The image focuses on safe disposal of the inner cap before use.*
FDA Label Image

Figure-j (Figure J)

Figure-j (Figure J)
An instructional diagram showing the adjustment of the dose dial on an insulin pen, likely for SEMGLEE (insulin glargine-yfgn) injection. The image depicts a hand turning the white dose selector on a blue pen with visible dose markings through a window, indicating dose selection steps.*
FDA Label Image

Figure-n (Figure N)

Figure-n (Figure N)
An illustration labeled as an example showing the selection of 48 units on a dosing dial, with the number 48 prominently displayed in black on a white background, accompanied by an arrow pointing to the selected dose. The image includes a pink header with white text indicating 'Example of 48 units selected.' This relates to dose selection for the SEMGLEE insulin glargine-yfgn injection.*
FDA Label Image

Figure-o (Figure O)

Figure-o (Figure O)
An instructional illustration showing a dosing dial example set at 49 units, featuring large black numbers on a white circular background, with contextual labels describing the selection. This appears to demonstrate dose setting on an injection device.*
FDA Label Image

Figure-p (Figure P)

Figure-p (Figure P)
Instructional illustration showing the proper technique for injecting SEMGLEE insulin glargine-yfgn solution subcutaneously. The image depicts a hand holding a syringe with the needle inserted into the skin of an arm and an arrow indicating the direction of injection.*
FDA Label Image

Figure-q (Figure Q)

Figure-q (Figure Q)
An instructional illustration showing a hand holding a vial and syringe, demonstrating how to check and remove the vial cap. The image emphasizes inspecting the vial cap for the pink color coding and indicates the removal direction by an arrow.*
FDA Label Image

Figure-r (Figure R)

Figure-r (Figure R)
An instructional illustration showing a hand holding a pen-like injection device with a visible dosage display. Next to it is a clock icon indicating a 10-second count, likely representing the recommended duration for holding the injection after administration.*
FDA Label Image

Figure-s (Figure S)

Figure-s (Figure S)
An instructional illustration showing a hand attaching or securing a protective cap onto or off a syringe needle above a medication vial, indicated by an arrow pointing downward labeled with the letter 'S' in pink. This image appears to be part of a guide for preparing a subcutaneous injection using SEMGLEE (insulin glargine-yfgn).*
FDA Label Image

Figure-t (Figure T)

Figure-t (Figure T)
An instructional illustration showing a hand removing a protective cap from a vial by twisting it, indicated by arrows labeled 1 and 2, as part of the preparation steps for injection.*
FDA Label Image

Figure-u (Figure U)

Figure-u (Figure U)
An instructional illustration showing a hand removing a cap from a vial, positioned next to a yellow sharps disposal container. The vial includes visible graduations and a rubber stopper, commonly used for injectable medication preparation.*
FDA Label Image

Figure-v (Figure V)

Figure-v (Figure V)
An instructional illustration showing a hand removing the blue safety cap from a prefilled injection syringe. The syringe contains a solution and is marked with dosage measurements, corresponding to SEMGLEE insulin glargine-yfgn 100 IU/mL subcutaneous injection.*
FDA Label Image

Figure-e (Figure E)

Figure-e (Figure E)
An instructional illustration depicting a hand lifting a metal cap from the top of a vial, showing a close-up of the vial's rubber stopper underneath the cap.*
FDA Label Image

Figure-c (Figure C)

Figure-c (Figure C)
An instructional illustration showing a hand removing a blue protective cap from the needle end of a syringe prefilled with injection solution. The syringe is marked with dose measurements, and a pink arrow indicates the direction to pull the cap off. This visual is part of administration instructions for SEMGLEE insulin glargine-yfgn 100 units/mL injection.*
FDA Label Image

Image-36 (Image 36)

Image-36 (Image 36)
Packaging label for Semglee (insulin glargine-yfgn) injection, 100 units/mL (U-100), a subcutaneous injection solution. The label states it is for single patient use only and contains five 3 mL prefilled pens. Manufactured by Biocon Biologics Inc., the label includes usage instructions and a barcode.*
FDA Label Image

Site Of Injection On Body (Image 01)

Site Of Injection On Body (Image 01)
Illustration showing recommended subcutaneous injection sites for SEMGLEE (insulin glargine-yfgn) injection solution. Highlighted areas include the upper arms, abdomen, and front and sides of the thighs on a human figure.*
FDA Label Image

Figure 1: Activity Profile In Patients With Type 1 Diabetes (Image 20)

Figure 1: Activity Profile In Patients With Type 1 Diabetes (Image 20)
A line graph comparing glucose infusion rates over time after subcutaneous injection for Insulin glargine and NPH insulin. The x-axis shows time in hours up to 30, and the y-axis shows glucose infusion rate in mg/kg/min. Insulin glargine shows a relatively flat infusion rate, while NPH insulin peaks earlier and declines. Markers indicate end of observation periods for both.*
FDA Label Image

Instructions For Use Step 1 (Image 02)

Instructions For Use Step 1 (Image 02)
An instructional illustration showing a hand holding a vial, with a syringe drawing solution from the vial through a needle. The image demonstrates the proper technique for withdrawing medication from a vial using a syringe.*
FDA Label Image

Instructions For Use Step 2 (Image 03)

Instructions For Use Step 2 (Image 03)
Illustration showing a close-up of hands preparing an injection vial for use. One hand is holding the vial while the other inserts or removes a vial stopper with a tab. The image focuses on proper handling technique for injection preparation.*
FDA Label Image

Instructions For Use Step 3 (Image 04)

Instructions For Use Step 3 (Image 04)
Instructional illustration showing a syringe held by a hand drawing solution from a vial, followed by an image of a needle being attached to the syringe by twisting. The diagrams depict steps for preparing an injection.*
FDA Label Image

Instructions For Use Step 4 (Image 05)

Instructions For Use Step 4 (Image 05)
An instructional illustration showing hands handling a syringe with a cap being removed or adjusted. The image depicts a step in preparing an injection, likely related to the subcutaneous administration process of SEMGLEE insulin glargine-yfgn injection, solution 100 units/mL by Biocon Biologics Inc.*
FDA Label Image

Instructions For Use Step 5 (Image 06)

Instructions For Use Step 5 (Image 06)
An instructional illustration showing a hand holding a vial and a syringe, demonstrating the process of drawing liquid from the vial into the syringe for injection preparation.*
FDA Label Image

Instructions For Use Step 7 (Image 07)

Instructions For Use Step 7 (Image 07)
An instructional illustration showing hands preparing to administer a subcutaneous injection using a syringe or pen device. One hand is holding the injection device while the other hand pinches the skin to form a fold, demonstrating proper injection technique.*
FDA Label Image

Instructions For Use Step 8 (Image 08)

Instructions For Use Step 8 (Image 08)
An instructional diagram showing two hands holding an insulin pen device for injection. The illustration appears to demonstrate preparing or administering a subcutaneous injection, relevant to the SEMGLEE insulin glargine-yfgn 100 IU/mL injection solution by Biocon Biologics Inc.*
FDA Label Image

Instructions For Use Pen (Image 09)

Instructions For Use Pen (Image 09)
An illustration of the SEMGLEE insulin glargine-yfgn injection pen components and their assembly. The diagram labels parts including the pen cap, cartridge holder, cartridge with rubber seal, pen body, insulin type indicator, expiration date window, dose pointer, dose window, dose knob, and injection button. Additional components like the pen needle with outer and inner caps, needle, and protective seal are shown but not included with the pen.*
FDA Label Image

Instructions For Use Figure A (Image 10)

Instructions For Use Figure A (Image 10)
SEMGLEE insulin glargine-yfgn injection, 100 units per mL, shown in a pen injector device. The label on the pen includes the brand name SEMGLEE and specifies the human prescription drug for subcutaneous use. The manufacturer is Biocon Biologics Inc.*
FDA Label Image

Instructions For Use Figure B (Image 11)

Instructions For Use Figure B (Image 11)
SEMGLEE 100 IU/mL insulin glargine-yfgn injection pen in solution form, designed for subcutaneous use. The image shows a close-up of the blue prefilled pen device manufactured by Biocon Biologics Inc., including a portion of the label indicating lot number and expiration date fields.*
FDA Label Image

Instructions For Use Figure D (Image 13)

Instructions For Use Figure D (Image 13)
SEMGLEE insulin glargine-yfgn injection, 100 units/mL (U-100) in a clear prefilled syringe with volume markings. The label on the syringe includes the brand name Semglee, concentration, and specifies use for single patient only. The product is manufactured by Biocon Biologics Inc.*
FDA Label Image

Instructions For Use Figure G (Image 16)

Instructions For Use Figure G (Image 16)
An instructional illustration showing how to prepare a syringe for use. It depicts fingers holding the syringe and twisting the needle cap to remove it, with arrows indicating the direction of movement. A circular inset highlights the grip on the needle cap during removal.*
FDA Label Image

Semglee Injection 100 Units/ml Vial Carton (Image 19)

Semglee Injection 100 Units/ml Vial Carton (Image 19)
Packaging label of Semglee (insulin glargine-yfgn) injection 100 units/mL (U-100), a subcutaneous injection solution. The label indicates a 10 mL multiple-dose vial, with instructions not to mix with other insulins and that the solution must be clear and colorless. The labeler is Biocon Biologics Inc. Storage directions and additional product details are also included.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.